Traumatic brain injury (TBI) is a silent global epidemic. Every year, an estimated 69 million people sustain...
Chemotherapy and Targeted Therapy
For decades, Bristol Myers Squibb (BMS) has cemented its status as a titan of the pharmaceutical industry...
In the high-stakes world of pharmaceutical development, where the average cost of bringing a single drug to...
In a high-stakes week for BioMarin Pharmaceutical, the company has secured a critical victory that promises to...
By Delilah Alvarado Published May 20, 2026 In a strategic maneuver that underscores the pharmaceutical industry’s pivot...
In a landmark decision that has sent shockwaves through the global pharmaceutical industry, Canada has officially become...
In a move that signals a seismic shift in the architecture of pharmaceutical research and development, Bristol...
WASHINGTON, D.C. — In a development that signals a profound shift in the regulatory landscape of the...
In a transformative move for the neurology sector, privately held biotech firm Mentari Therapeutics has announced a...
By Ben Fidler | Published May 18, 2026 Regeneron Pharmaceuticals, long considered a gold standard in the...
